InvestorsHub Logo

H2R

Followers 41
Posts 2214
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Monday, 10/30/2017 3:03:52 PM

Monday, October 30, 2017 3:03:52 PM

Post# of 1570
Great Long term Stock Potential Even if Tirasemtiv Were to Fail in Vitality-ALS. (CYTK, $14.25, Buy)

A new article by SoS

https://smithonstocks.com/cytokinetics-even-if-tirasemtiv-were-to-fail-in-vitality-als-there-is-great-long-term-stock-potential-cytk-14-25-buy/

His take on the PPS, in case of good top line data for VITALITY-ALS (Phase III / tirasemtiv in ALS) is around double today's PPS.

He also talks about the other two potential blockbusters.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News